Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Smith P, Bradley T, Gavarró LM, Goranova T, Ennis DP, Mirza HB, De Silva D, Piskorz AM, Sauer CM, Al-Khalidi S, Funingana IG, Reinius MAV, Giannone G, Lewsley LA, Stobo J, McQueen J, Bryson G, Eldridge M; BriTROC Investigators; Macintyre G, Markowetz F, Brenton JD, McNeish IA. Smith P, et al. Among authors: stobo j. Nat Commun. 2023 Jul 20;14(1):4387. doi: 10.1038/s41467-023-39867-7. Nat Commun. 2023. PMID: 37474499 Free PMC article.
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Smith P, Bradley T, Gavarró LM, Goranova T, Ennis DP, Mirza HB, De Silva D, Piskorz AM, Sauer CM, Al-Khalidi S, Funingana IG, Reinius MAV, Giannone G, Lewsley LA, Stobo J, McQueen J, Bryson G, Eldridge M; BriTROC Investigators; Macintyre G, Markowetz F, Brenton JD, McNeish IA. Smith P, et al. Among authors: stobo j. Nat Commun. 2023 Sep 26;14(1):5992. doi: 10.1038/s41467-023-41611-0. Nat Commun. 2023. PMID: 37752102 Free PMC article. No abstract available.
Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Derby S, Jackson MR, Williams K, Stobo J, Kelly C, Sweeting L, Shad S, Herbert C, Short SC, Williamson A, James A, Nowicki S, Bulbeck H, Chalmers AJ. Derby S, et al. Among authors: stobo j. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1371-1378. doi: 10.1016/j.ijrobp.2024.01.011. Epub 2024 Jan 9. Int J Radiat Oncol Biol Phys. 2024. PMID: 38211641 Free article. Clinical Trial.
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.
Horne GA, Stobo J, Kelly C, Mukhopadhyay A, Latif AL, Dixon-Hughes J, McMahon L, Cony-Makhoul P, Byrne J, Smith G, Koschmieder S, BrÜmmendorf TH, Schafhausen P, Gallipoli P, Thomson F, Cong W, Clark RE, Milojkovic D, Helgason GV, Foroni L, Nicolini FE, Holyoake TL, Copland M. Horne GA, et al. Among authors: stobo j. Leukemia. 2020 Jul;34(7):1775-1786. doi: 10.1038/s41375-019-0700-9. Epub 2020 Jan 10. Leukemia. 2020. PMID: 31925317 Free PMC article. Clinical Trial.
Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
Goranova T, Ennis D, Piskorz AM, Macintyre G, Lewsley LA, Stobo J, Wilson C, Kay D, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Freeman S, Moore L, Jimenez-Linan M, Paul J, Brenton JD, McNeish IA; BriTROC investigators. Goranova T, et al. Among authors: stobo j. Br J Cancer. 2019 Apr;120(8):868. doi: 10.1038/s41416-019-0433-6. Br J Cancer. 2019. PMID: 30862952 Free PMC article.
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.
Ashton M, O'Rourke N, Macleod N, Laird B, Stobo J, Kelly C, Alexander L, Franks K, Moore K, Currie S, Valentine R, Chalmers AJ. Ashton M, et al. Among authors: stobo j. Clin Transl Radiat Oncol. 2017 Nov 21;8:45-49. doi: 10.1016/j.ctro.2017.11.004. eCollection 2018 Jan. Clin Transl Radiat Oncol. 2017. PMID: 29594241 Free PMC article.
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.
Fulton B, Short SC, James A, Nowicki S, McBain C, Jefferies S, Kelly C, Stobo J, Morris A, Williamson A, Chalmers AJ. Fulton B, et al. Among authors: stobo j. Clin Transl Radiat Oncol. 2017 Nov 21;8:12-16. doi: 10.1016/j.ctro.2017.11.003. eCollection 2018 Jan. Clin Transl Radiat Oncol. 2017. PMID: 29594237 Free PMC article.
Reply to M. Horiguchi et al.
Paul J, Kelly C, Stobo J, Powles T. Paul J, et al. Among authors: stobo j. J Clin Oncol. 2017 Oct 10;35(29):3373-3374. doi: 10.1200/JCO.2017.74.4292. Epub 2017 Aug 11. J Clin Oncol. 2017. PMID: 28800270 Free article. No abstract available.
Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer.
Jones RJ, Hussain SA, Protheroe AS, Birtle A, Chakraborti P, Huddart RA, Jagdev S, Bahl A, Stockdale A, Sundar S, Crabb SJ, Dixon-Hughes J, Alexander L, Morris A, Kelly C, Stobo J, Paul J, Powles T. Jones RJ, et al. Among authors: stobo j. J Clin Oncol. 2017 Jun 1;35(16):1770-1777. doi: 10.1200/JCO.2016.70.7828. Epub 2017 Apr 12. J Clin Oncol. 2017. PMID: 28402747 Free article. Clinical Trial.
122 results